These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5194692)

  • 21. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of urinary tract infections: striking Gram-negative germs. Changes in the bacterial spectrum and resistance in a group of patients over an 18-year period].
    Gussmann S
    Fortschr Med; 1983 Sep; 101(36):1626-9. PubMed ID: 6629294
    [No Abstract]   [Full Text] [Related]  

  • 23. [Application of ampicillin-cloxacillin (Viccillin S Meiji) in the field of urology].
    Ishigami J; Hara S; Mita T
    Jpn J Antibiot; 1969 Oct; 22(5):372-7. PubMed ID: 4903720
    [No Abstract]   [Full Text] [Related]  

  • 24. Experimental studies of amoxycillin-flucloxacillin combination.
    Ripa S; Prenna M; Vitali C
    Antibiotica; 1974 Jun; 12(2):88-106. PubMed ID: 4470369
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Clumeck N; Van Laethem Y; Vanhoof R; Jaspar N; George G; Rapin M; Butzler JP
    Nouv Presse Med; 1981 Feb; 10(8):622-4. PubMed ID: 6259606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Survey of the present danger of multi-resistance gram-negative bacilli].
    Duval J; Gaudin H; Le Bouar Y
    Pathol Biol; 1967 Dec; 15(23):1216-21. PubMed ID: 4966392
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ampicillin-cloxacillin combination with regard to the study of acute and subacute toxicity].
    Dominici A; Ravagnan G
    Antibiotica; 1969 Dec; 7(4):282-91. PubMed ID: 5407464
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sensitivity of Streptococcus and Staphylococcus of various serological and bacteriophage groups to lincomycin; resistance of Gram-negative bacteria in urinary infections].
    von Hubinger MG; Suassuna I; Suassuna IR; Oliveira Lde A
    Hospital (Rio J); 1966 Apr; 69(4):691-9. PubMed ID: 5295887
    [No Abstract]   [Full Text] [Related]  

  • 29. [Investigation in vitro synergism on ampicillin with cloxacillin and dibekacin against glucose non-fermenting gram-negative bacilli and Serratia (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1978 Oct; 31(10):610-3. PubMed ID: 366194
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on synergistic action against penicillin and cephalosporin resistant bacteria. II: Clinical evaluations of synergistic action in urinary tract infections].
    Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 1970 May; 61(5):473-84. PubMed ID: 5200441
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of urinary tract infections. Open comparative trial.
    Bernstein-Hahn L; Sember ME
    Int Surg; 1971 Jul; 56(1):8-12. PubMed ID: 5563422
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experience of ampicillin-dicloxacillin (Combipenix) in complicated urinary tract infections (author's transl)].
    Takahashi Y; Mita T; Ishigami J
    Jpn J Antibiot; 1977 Aug; 30(8):612-8. PubMed ID: 242608
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bacterial pathogens and resistance patterns in community acquired pediatric urinary tract infection: experience of 152 cases].
    Fan SY; Zhang BL; Wang WH; Zhang X
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):115-7. PubMed ID: 16613703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 35. [Oral administration of propicillin, ampicillin and dicloxacillin in infants].
    Marget W; Wagner M
    Med Klin; 1967 Feb; 62(8):300-5. PubMed ID: 4967932
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical results in the use of the oxacillin-ampicillin mixture (Broadcillin "Banyu")].
    Tsubura E; Tsujimoto H; Tachibana T; Hara M; Uo Y
    Jpn J Antibiot; 1970 Apr; 23(2):99-102. PubMed ID: 5311046
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic experience in respiratory infections with ampicillin-cloxacillin (Viccillin S 'Meiji') (author's transl)].
    Kudo K; Mori S
    Jpn J Antibiot; 1978 Nov; 31(11):677-80. PubMed ID: 731863
    [No Abstract]   [Full Text] [Related]  

  • 38. Transferable drug resistance (R-factor) among the enterobacteriaceae in urinary tract infections: a study at an urban hospital in Bangladesh.
    Chowdhury MA; Rahman KM; Miah MR; Haq JA
    J Trop Med Hyg; 1994 Jun; 97(3):161-6. PubMed ID: 8007056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of a combination of penicillin and kanamycin in treatment of urinary infections].
    Auvray P
    Brux Med; 1968 Mar; 48(3):171-5. PubMed ID: 5674283
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tolerance of a new antibiotic association, ampicillin and cloxacillin, administered intravenously].
    Zanotelli F; Sabbioni S
    Minerva Med; 1973 Apr; 64(21):1094-7. PubMed ID: 4574203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.